Results 1-18 of 18 (Search time: 0.004 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2023 | Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma | Chen, KJ; Huang, JH; Shih, JH; Gu, DL; Lee, SS; Shen, R; Hsu, YH; Kung, YC; Wu, CY; Ho, CM; Jen, HW; Lee, HY; Lang, YD; Hsiao, CH; Jou, YS | Molecular carcinogenesis 62(3), 348-359 | |||
2 | 2022 | Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs | Nicholson, MW; Huang, CY; Wang, JY; Ting, CY; Cheng, YC; Chan, DZH; Lee, YC; Hsu, CC; Hsu, YH; Chang, CMC; Hsieh, ML; Cheng, YY; Lin, YL ; Chen, CH ; Wu, YT ; Hacker, TA; Wu, JC; Kamp, TJ; Hsieh, PCH | Pharmaceuticals. 15(6), 765 | |||
3 | 2022 | Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons | Huang, CY; Nicholson, MW; Wang, JY; Ting, CY; Tsai, MH; Cheng, YC; Liu, CL; Chan, DZH; Lee, YC; Hsu, CC; Hsu, YH; Yang, CF; Chang, CM; Ruan, SC; Lin, PJ; Lin, JH; Chen, LL; Hsieh, ML; Cheng, YY; Hsu, WT; Chen, CH ; Hsu, YH; Wu, YT ; Hacker, TA; Wu, JC; Kamp, TJ; Hsieh, PC | Cell Reports 39(1), 110643 | |||
4 | 2022 | Taiwan Biobank: A rich biomedical research database of the Taiwanese population | Feng, YA; Chen, CY; Chen, TT; Kuo, PH; Hsu, YH; Yang, HI ; Chen, WJ; Su, MW; Chu, HW; Shen, CY ; Ge, T; Huang, H; Lin, YF | Cell Genomics 2(11), 100197 | |||
5 | 2021 | Convenient Auto-Processing Vector Based on Bamboo Mosaic Virus for Presentation of Antigens Through Enzymatic Coupling | Yang, MH; Hu, CC; Wong, CH; Liang, JJ; Ko, HY; He, MH; Lin, YL ; Lin, NS ; Hsu, YH | Frontiers in immunology 12, 739837 | |||
6 | 2018 | Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant | Cheng, YC; Huang, CY; Ho, MC; Hsu, YH; Syu, SH; Lu, HE; Lin, HI; Lin, CH; Hsieh, PC | Stem Cell Research 28, 1-5 | |||
7 | 2018 | Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation | Liu, SP; Hsu, YH; Huang, CY; Ho, MC; Cheng, YC; Wen, CH; Lu, HE; Tsai, CH; Shyu, WC; Hsieh, PC | Stem Cell Research 28, 39-43 | |||
8 | 2017 | Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene | Hsu, YH; Wu, YT; Huang, CY; Ho, MC; Cheng, YC; Syu, SH; Lu, HE; Chen, YC; Tsai, CL; Lin, HC; Wei, YH; Hsu, YC; Hsieh, PC | Stem Cell Research 25, 245-249 | |||
9 | 2017 | Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation | Lin, CH; Cheng, YC; Lin, HI; Ho, MC; Hsu, YH; Wen, CH; Ko, HW; Lu, HE; Huang, CY; Hsieh, PC | Stem Cell Research 25, 123-127 | |||
10 | 2017 | Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2 | Ho, MC; Huang, CY; Lee, JJ; Hsu, SH; Cheng, YC; Hsu, YH; Hwang, DY; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 25, 38-41 | |||
11 | 2017 | Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation | Lee, JJ; Ho, MC; Huang, CY; Wen, CH; Cheng, YC; Hsu, YH; Hwang, DY; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 25, 83-87 | |||
12 | 2017 | Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1 | Huang, CY; Ho, MC; Lee, JJ; Hwang, DY; Ko, HW; Cheng, YC; Hsu, YH; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 24, 139-143 | |||
13 | 2016 | Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. | Wang, Y; Hsu, JM; Kang, Y; Wei, Y; Lee, PC; Chang, SJ; Hsu, YH; Hsu, JL; Wang, HL; Chang, WC; Li, CW ; Liao, HW; Chang, SS; Xia, W; Ko, HW; Chou, CK; Fleming, JB; Wang, H; Hwang, RF; Chen, Y; Qin, J; Hung, MC | Cancer research 76(23), 7049-7058 | |||
14 | 2016 | Deubiquitination and Stabilization of PD-L1 by CSN5. | Lim, SO; Li, CW ; Xia, W; Cha, JH; Chan, LC; Wu, Y; Chang, SS; Lin, WC; Hsu, JM; Hsu, YH; Kim, T; Chang, WC; Hsu, JL; Yamaguchi, H; Ding, Q; Wang, Y; Yang, Y; Chen, CH; Sahin, AA; Yu, D; Hortobagyi, GN; Hung, MC | Cancer cell 30(6), 925-939 | |||
15 | 2016 | AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. | Li, CW ; Xia, W; Lim, SO; Hsu, JL; Huo, L; Wu, Y; Li, LY; Lai, CC; Chang, SS; Hsu, YH; Sun, HL; Kim, J; Yamaguchi, H; Lee, DF; Wang, H; Wang, Y; Chou, CK; Hsu, JM; Lai, YJ; LaBaff, AM; Ding, Q; Ko, HW; Tsai, FJ; Tsai, CH; Hortobagyi, GN; Hung, MC | Cancer research 76(6), 1451-1462 | |||
16 | 2016 | Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection. | Wu, TJ; Chang, SS; Li, CW ; Hsu, YH; Chen, TC; Lee, WC; Yeh, CT; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 22(7), 1800-1812 | |||
17 | 2015 | Selective expression of constitutively active pro-apoptotic protein BikDD gene in primary mammary tumors inhibits tumor growth and reduces tumor initiating cells. | Rahal, OM; Nie, L; Chan, LC; Li, CW ; Hsu, YH; Hsu, J; Yu, D; Hung, MC | American journal of cancer research 5(12), 3624-3634 | |||
18 | 2014 | Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. | Hsu, YH; Yao, J; Chan, LC; Wu, TJ; Hsu, JL; Fang, YF; Wei, Y; Wu, Y; Huang, WC; Liu, CL; Chang, YC; Wang, MY; Li, CW ; Shen, J; Chen, MK; Sahin, AA; Sood, A; Mills, GB; Yu, D; Hortobagyi, GN; Hung, MC | Cancer research 74(17), 4822-4835 |